Home Industries Reports Services About Us Publisher Contact us

Global Fabry Disease Treatment Market - By Product (Enzyme Replacement Therapy (ERT), Chaperone Treatment, Substrate Reduction Therapy (SRT), Others), By Application (Hospital, Clinic, Others) - Trends and Forecast to 2030

Type: PDF

Status: Syndicate

Categories: Biotechnology

Report Code : BT23

No. of Pages : 150

Fabry disease also known as Anderson-Fabry disease an alpha-galactosidase-A insufficiency is an X-linked, genetic, lysosomal storage disease caused owing to the scarcity of an enzyme α galactosidase A. The mutated gene results in the formation of lipids to harmful levels in several parts of body such as the autonomic nervous system, cardiovascular system, eyes, and kidneys. The rising adoption of new therapies such as chaperone treatment is obtaining prominence due to its efficacy, which is expected to be a vital factor which can boost the fabry disease market.

The global fabry disease treatment market in 2023 was approximately USD 2.7 million. The market is expected to grow at a CAGR of 7.7% and is anticipated to reach around USD 3.2 million by 2030. The escalating demand for messenger RNA (mRNA) as another effectual treatment method for Fabry disease is likely to favor the market growth during the forecast period. Several other factors such as technological development in research activities and developing healthcare infrastructure are projected to be other causes which can enhance the demand for treatment and fuel the market. Moreover, the less diagnostic rate owing to unavailability of such diagnostic procedures and trained professionals are likely to impede the market growth.

The market for fabry disease treatment is intensely competitive and is highly fragmented. The vendors in the biodegradable mulch film market compete based on product portfolio, product differentiation, applications, and the pricing of products.

The rise in technological innovations in designing the products for better quality, ease of use and better performance is expected to continue to intensify the level of competition among the companies to expand their product portfolios by incorporating innovative features, into their product. Key players in the market are Sanofi S.A., Shire Plc, Amicus Therapeutics Inc., SU Abxis Co Ltd., JCR Pharmaceuticals Co Ltd., Protalix Biotherapeutics Inc., Idorsia Pharmaceuticals Ltd., Avrobio Inc., Greenovation Biotech GmbH, Moderna Therapeutics Inc., & Green Cross Pharma Pte Ltd.

Request For List of Tables

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any), so we can get back to you with a solution

Table of Contents

  1. Introduction
    • Key Insights
    • Report Overview
    • Markets Covered
    • Stakeholders

 

  1. Research Methodology
    • Research Scope
    • Market Research Process
    • Research Data Analysis
      • Secondary Research
      • Primary Research
      • Models for Estimation
    • Market Size Estimation
      • Bottom-Up Approach - Segmental Market Analysis
      • Top-Down Approach - Parent Market Analysis             
  1. Executive Summary             
  2. Market Overview
    • Introduction
      • Drivers
      • Restraints
      • Opportunities
      • Challenges
    • Porter's Five Force Analysis                             
  3. Global Fabry Disease Treatment Market, By Product
    • Introduction
    • Enzyme Replacement Therapy (ERT)
      • Market Overview
      • Market Size and Forecast
    • Chaperone Treatment
      • Market Overview
      • Market Size and Forecast
    • Substrate Reduction Therapy (SRT)
      • Market Overview
      • Market Size and Forecast
    • Others
      • Market Overview
      • Market Size and Forecast                                                                                   
  1. Global Fabry Disease Treatment Market, By Application
    • Introduction
    • Hospital
      • Market Overview
      • Market Size and Forecast
    • Clinic
      • Market Overview
      • Market Size and Forecast
    • Others
      • Market Overview
      • Market Size and Forecast                                                               
  1. Global Fabry Disease Treatment Market, By Geography
    • Introduction
    • North America
      • North America Global Fabry Disease Treatment Market, By Type
      • North America Global Fabry Disease Treatment Market, By Applications
    • Europe
      • Europe Global Fabry Disease Treatment Market, By Type
      • Europe Global Fabry Disease Treatment Market, By Applications
    • Asia-Pacific
      • Asia-Pacific Global Fabry Disease Treatment Market, By Type
      • Asia-Pacific Global Fabry Disease Treatment Market, By Applications
    • Rest of the World
      • Rest of the World Global Fabry Disease Treatment Market, By Type
      • Rest of the World Global Fabry Disease Treatment Market, By Applications
  1. Competitive Insights
    • Key Insights
    • Company Market Share Analysis
    • Strategic Outlook
      • Mergers & Acquisitions
      • New Product Development
      • Portfolio/Production Capacity Expansions
      • Joint Ventures, Collaborations, Partnerships & Agreements
      • Others                                 
  1. Company Profiles
    • Sanofi S.A.
      • Company Overview
      • Product/Service Landscape
      • Financial Overview
      • Recent Developments
    • Shire Plc.
      • Company Overview
      • Product/Service Landscape
      • Financial Overview
      • Recent Developments
    • Amicus Therapeutics Inc.
      • Company Overview
      • Product/Service Landscape
      • Financial Overview
      • Recent Developments
    • ISU Abxis Co Ltd.
      • Company Overview
      • Product/Service Landscape
      • Financial Overview
      • Recent Developments
    • JCR Pharmaceuticals Co Ltd.
      • Company Overview
      • Product/Service Landscape
      • Financial Overview
      • Recent Developments
    • Protalix Biotherapeutics Inc.
      • Company Overview
      • Product/Service Landscape
      • Financial Overview
      • Recent Developments
    • Idorsia Pharmaceuticals Ltd.
      • Company Overview
      • Product/Service Landscape
      • Financial Overview
      • Recent Developments
    • Avrobio Inc.
      • Company Overview
      • Product/Service Landscape
      • Financial Overview
      • Recent Developments
    • Greenovation Biotech GmbH
      • Company Overview
      • Product/Service Landscape
      • Financial Overview
      • Recent Developments
    • Moderna Therapeutics Inc.
      • Company Overview
      • Product/Service Landscape
      • Financial Overview
      • Recent Developments
    • Green Cross Pharma Pte Ltd.
      • Company Overview
      • Product/Service Landscape
      • Financial Overview
      • Recent Developments
    • Others
      • Company Overview
      • Product/Service Landscape
      • Financial Overview
      • Recent Developments

Request For Research Methodology

To receive a sample copy of this report, please complete the form below

Kindly share your specific requirement (if any), so we can get back to you with a solution
Global United Research

Report Code

BT23

Single User

US$ 3500

Multi User

US$ 5250

Corporate User

US$ 7000

Related Reports

Global Fabry Disease Treatment Market - By Product...

RD Code : BT23